Literature DB >> 7964982

Response of multicellular tumor spheroids to liposomes containing TNF-alpha.

F Weber1, C Kremer, M Klinkhammer, B Rasier, M Brock.   

Abstract

This publication describes a new model to investigate the influence of tumor necrosis factor-alpha (TNF-alpha) on a three-dimensional glial cell aggregate under defined, standardized, reproducible conditions using the glioma cell line A 172. The cells are initially grown as normal monolayer culture until they reach a cell density of up to 1 x 10(6). Subsequently they are grown as spheroids by the liquid overlay technique. Spheroids grown in this way were divided into ten groups of more than 50 cell aggregates. Three groups were coincubated with free TNF-alpha in increasing dosages (100 ng/ml, 200 ng/ml and 1000 ng/ml); three groups were incubated with empty liposomes (0.2 mg/ml, 0.4 mg/ml and 2 mg/ml); three groups received liposomes which had been loaded with TNF-alpha, and one group, which received no treatment, served as control. The diameter of the spheroids ranged from 80 microns to 350 microns. There was no significant difference in growth between the 3 groups treated with 'free' TNF-alpha. Comparing spheroids treated with TNF-alpha with those which had been coincubated with empty liposomes, there was a significant difference (p < 0.001) in growth, which correlated with the amount of liposomes. Similarly, free TNF-alpha had a significantly (P < 0.001) stronger growth-inhibiting effect as compared to liposomes loaded with TNF-alpha. Comparing the groups treated with liposomes only to those treated with liposomes loaded with TNF-alpha, the latter exhibited a more marked (although not significantly) growth-inhibiting effect. The preliminary conclusion is that the major growth-inhibiting effect seems to be mediated by the liposomes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964982     DOI: 10.1007/BF01328956

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  14 in total

Review 1.  Role of superoxide dismutase in cancer: a review.

Authors:  L W Oberley; G R Buettner
Journal:  Cancer Res       Date:  1979-04       Impact factor: 12.701

2.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein).

Authors:  J M McCord; I Fridovich
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

3.  An approach to free radicals in medicine and biology.

Authors:  R F Del Maestro
Journal:  Acta Physiol Scand Suppl       Date:  1980

4.  Cell differentiation, aging and cancer: the possible roles of superoxide and superoxide dismutases.

Authors:  L W Oberley; T D Oberley; G R Buettner
Journal:  Med Hypotheses       Date:  1980-03       Impact factor: 1.538

5.  Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor.

Authors:  G H Wong; J H Elwell; L W Oberley; D V Goeddel
Journal:  Cell       Date:  1989-09-08       Impact factor: 41.582

Review 6.  Cytotoxic mechanism of tumor necrosis factor-alpha.

Authors:  J W Larrick; S C Wright
Journal:  FASEB J       Date:  1990-11       Impact factor: 5.191

7.  Tumor necrosis factor provokes superoxide anion generation from neutrophils.

Authors:  M Tsujimoto; S Yokota; J Vilcek; G Weissmann
Journal:  Biochem Biophys Res Commun       Date:  1986-06-30       Impact factor: 3.575

8.  Intracellular hydroxyl radical production induced by recombinant human tumor necrosis factor and its implication in the killing of tumor cells in vitro.

Authors:  N Yamauchi; H Kuriyama; N Watanabe; H Neda; M Maeda; Y Niitsu
Journal:  Cancer Res       Date:  1989-04-01       Impact factor: 12.701

9.  Oxidative damage in murine tumor cells treated in vitro by recombinant human tumor necrosis factor.

Authors:  R J Zimmerman; A Chan; S A Leadon
Journal:  Cancer Res       Date:  1989-04-01       Impact factor: 12.701

10.  Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells.

Authors:  M Tsujimoto; Y K Yip; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.